What is the use of Bentyl (dicyclomine) in treating irritable bowel syndrome (IBS) symptoms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bentyl (Dicyclomine) for Irritable Bowel Syndrome

Bentyl (dicyclomine) is an effective antispasmodic medication for treating abdominal pain in irritable bowel syndrome (IBS), with clinical trials showing 82% of patients demonstrating favorable clinical response compared to 55% with placebo. 1

Mechanism and Efficacy

Dicyclomine is an anticholinergic antispasmodic that works by reducing smooth muscle contractions in the gastrointestinal tract and potentially decreasing visceral hypersensitivity. 2 The FDA has specifically approved dicyclomine for the treatment of functional bowel/irritable bowel syndrome. 1

Key evidence supporting its use:

  • In controlled clinical trials, 82% of patients treated with dicyclomine at initial doses of 160 mg daily (40 mg four times daily) showed favorable clinical response compared with 55% treated with placebo (p<0.05). 1
  • Antispasmodics as a class have demonstrated improvement in abdominal pain compared to placebo (RR 0.74; 95% CI 0.59-0.93). 2
  • Studies have shown dicyclomine is superior to placebo in improving overall condition, decreasing abdominal pain and tenderness, and improving bowel habits. 3

Dosing Recommendations

  • Standard dosing: 20 mg initially, which can be increased to 40 mg daily after 2-4 weeks 2
  • For patients with daily symptoms, especially after meals, dicyclomine before meals is useful 4
  • Clinical trials showing efficacy used 40 mg four times daily 1, 3

Clinical Application

Dicyclomine is particularly useful for:

  • Treating abdominal pain associated with IBS 2, 5
  • Managing postprandial symptoms, though this specific use hasn't been extensively studied in RCTs 2
  • Intermittent use in response to periods of increased abdominal pain, cramps, and urgency 4

Side Effects and Precautions

The most common adverse effects are related to dicyclomine's anticholinergic activity 3:

  • Dry mouth
  • Dizziness
  • Blurred vision

Important precautions:

  • Should be avoided in elderly patients who are more sensitive to anticholinergic effects 5
  • Regular use in constipation-predominant IBS may be limited due to its anticholinergic effects 2
  • For most patients, it's recommended that oral antispasmodics be used for limited periods rather than indefinitely, particularly during times when symptoms are prominent 4

Place in IBS Treatment Algorithm

  1. First-line non-pharmacological approaches:

    • Dietary modifications
    • Regular exercise
    • Stress management
  2. For abdominal pain in IBS:

    • Antispasmodics like dicyclomine are suggested by the American Gastroenterological Association (conditional recommendation, low certainty in evidence) 2
    • Tricyclic antidepressants are recommended as first-line drug for IBS pain management by some guidelines 5
  3. For specific symptom management:

    • Dicyclomine for abdominal pain and cramping 2, 5
    • Loperamide for diarrhea 2, 5
    • Fiber supplements for constipation 2, 5

While dicyclomine has demonstrated efficacy for IBS symptoms, it's worth noting that some newer medications like peppermint oil, rifaximin, lubiprostone, and linaclotide have more reliable evidence supporting their use in certain IBS subtypes. 6

The British Society of Gastroenterology specifically lists dicyclomine as an anticholinergic agent for abdominal pain in IBS, highlighting its role in symptom management. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Irritable Bowel Syndrome.

Current treatment options in gastroenterology, 1999

Guideline

Managing Irritable Bowel Syndrome (IBS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.